Regenerative medicine*1
is drawing attention as a new form of medicine that utilizes cells from a patient’s own body. In order to successfully complete a cell’s journey, which is a series of connected safe and reliable processes from collecting the cells to administering the resulting product (the therapeutic agent) into patients, medical service providers must centralize management of information about a regenerative therapy, establish traceability, and connect the series of all these processes. This article provides a customer case in which a medical service provider manages information and traceability in the entire value chain to maintain and improve the safety of regenerative medicine.
*1
Regenerative medicine is based on the idea that a tissue or organ lost as a result of a disease or injury can be regenerated by creating a therapeutic agent (such as a drug or tissue) through the use of cells or similar objects collected from a patient or donor, and then administering the therapeutic agent to the patient.
